ABSORBENT STRUCTURE FOR ABSORBENT ARTICLES

SIRNAS AGAINST KRAS AND RAF1

ALPHA-1 ANTITRYPSIN (AAT) RNAI AGENTS, COMPOSITIONS INCLUDING AAT RNAI AGENTS, AND METHODS OF USE

RNA DELIVERY SYSTEM FOR TREATMENT OF HUNTINGTON'S DISEASE

RNA PLASMID DELIVERY SYSTEM AND APPLICATION THEREOF

T-cell modulatory multimeric polypeptides and methods of use thereof

THERAPEUTIC OLIGONUCLEOTIDES

Inhibitors of menin-MLL interaction

SMALL EXTRACELLULAR VESICLES FOR ATTENUATING POST-OPERATIVE PAIN

COPPER HISTIDINATE COMPOSITIONS AND USES THEREOF

TREATMENT FOR AORTOPATHY

USE OF EZH2 INHIBITORS FOR TREATING CANCER

Methods of use of emulsion formulations of aprepitant

METHODS FOR INDUCING PUPIL DILATION

Compounds for treating TNBC

COMPOSITION INCLUDING DECURSINOL AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING SMOOTH MUSCLE CELL PROLIFERATIVE DISEASES

NON-AQUEOUS INJECTABLE COMPOSITION OR SUSTAINED RELEASE OF BUPRENORPHINE AND USE THEREOF

Compositions and methods for stimulating ventilatory and/or respiratory drive

Injectable Nitrogen Mustard Compositions Comprising a Cyclodextrin Derivative and Methods of Making and Using the Same

LIPID NANOPARTICLE WITH TARGET INTEGRIN FUNCTION AND USES THEREOF

Methods of use of emulsion formulations of an NK-1 receptor antagonist

PHARMACEUTICAL COMPOSITION CONTAINING GHRP-6

INJECTABLE COMPOSITIONS

RADIATION SENSITIZER OF ANTI-CANCER CHEMOTHERAPY SENSITIZER

NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES

METHODS AND COMPOSITIONS FOR T-CELL COCULTURE POTENCY ASSAYS AND USE WITH CELL THERAPY PRODUCTS

Methods of producing RPE cells

PLATFORM TECHNOLOGY FOR TREATMENT OF INFLAMMATORY, IMMUNOLOGICAL AND/OR AUTOIMMUNOLOGICAL DISEASES

HER2/neu-Specific Antibodies and Methods of Using Same

LASSA VIRUS VACCINE AND USES THEREOF

Use of pertussis toxin as a therapeutic agent

PROTEIN-BASED THERAPIES FOR OCULAR CONDITIONS

ONCOLYTIC VIRUS COMBINED WITH CAR T CELLS FOR ANTI-TUMOR THERAPY

MIR200C-EPCAM AXIS REPROGRAMED IMMUNE CELLS FOR ENHANCED ANTI-TUMOR FUNCTION

COMPOSITIONS AND METHODS FOR SELECTIVE ELIMINATION AND REPLACEMENT OF HEMATOPOIETIC STEM CELLS

SODIUM BICARBONATE INJECTABLE FORMULATION AND METHODS THEREOF

Anionically Charged Chitosan

PHARMACEUTICAL COMPOSITIONS COMPRISING SORBITAN ESTERS

ENHANCEMENT OF MICROFRACTURE FOR REPAIRING CARTILAGE DEFECTS VIA WNT INHIBITION

AMINONAPHTHOQUINONE COMPOUNDS FOR TREATMENT AND/OR PREVENTION OF FIBROSIS DISEASES

TREATMENT OF AVASCULAR OR HYPOVASCULAR MICRO-TUMORS

NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES

NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES

NEUROMODULATION FOR METABOLIC CONDITIONS OR SYNDROMES

COMPOUNDS FOR TREATMENT OF OSTEOARTHRITIS

METHODS FOR TREATING PROGRESSIVE MULTIPLE SCLEROSIS

Thermoresponsive or Shear-Thinning Injectable Gel Compositions for Treatment of Arthritis

Modulation of Wnt5a to Treat Glaucoma

OPTIMIZED PEPTIDES FOR TARGETING HUMAN NERVES AND THEIR USE IN IMAGE GUIDED SURGERY, DIAGNOSTICS AND THERAPEUTIC DELIVERY

Monocyclic And Bicyclic Ring System Substituted Carbanucleoside Analogues For Use As PRMT5 Inhibitors

INJECTABLE LURASIDONE SUSPENSION AND PREPARATION METHOD THEREFOR

Compounds and compositions for intracellular delivery of therapeutic agents

LIVER SPECIFIC DELIVERY OF MESSENGER RNA

Hydrogel prodrug for treatment

Vaccines For Recurrent Respiratory Papillomatosis And Methods of Using the Same

Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virus

PTH prodrugs

MODIFIED NUCLEOSIDE, NUCLEOTIDE, AND NUCLEIC ACID COMPOSITIONS

METHODS OF TREATING LIVER DISEASES

A STABLE ANTI-ANGIOGENIC AND ANTI-INFLAMMATORY PHARMACEUTICAL FORMULATION AND PHARMACEUTICAL COMBINATION FOR TREATMENT AND PREVENTION OF PSORIASIS

PHARMACEUTICAL COMPOSITIONS

GENE THERAPIES FOR LYSOSOMAL DISORDERS

SYNAPSE FORMATION AGENT

PROLYL HYDROXYLASE DOMAIN INHIBITOR TREATMENT TO IMPROVE SURVIVABILITY OF HEMORRHAGIC SHOCK

CD38-NAD+ REGULATED METABOLIC AXIS IN ANTI-TUMOR IMMUNOTHERAPY

COMPOSITIONS AND METHODS FOR PARENTERAL ADMINISTRATION OF THERAPEUTIC AGENTS

CARRIER FOR SUSTAINED-RELEASE OF DRUG AND USE THEREOF

MICROBIAL COMPOSITIONS AND METHODS OF USE FOR IMPROVING MILK PRODUCTION

ANTI-GLP1R ANTAGONIST ANTIBODIES AND METHODS OF USE THEREOF

REMOVAL OF SERINE PROTEASES BY TREATMENT WITH FINELY DIVIDED SILICON DIOXIDE

GLUCAGON LIKE PEPTIDE 1 (GLP-1) FUSION PEPTIDE COUPLED CYCLIC PEPTIDE TYROSINE TYROSINE CONJUGATES AND USES THEREOF

THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS

Ergoline analogues

FORMULATIONS AND METHODS FOR DIRECT SODIUM REMOVAL IN PATIENTS HAVING HEART FAILURE AND/OR SEVERE RENAL DYSFUNCTION

GENE THERAPY FOR DOPAMINE TRANSPORTER DEFICIENCY SYNDROME

MATERIALS AND METHODS FOR THE TREATMENT OF LYSOSOMAL ACID LIPASE DEFICIENCY (LAL-D)

COMPOSITIONS AND METHODS FOR TREATMENT OF NIEMANN PICK TYPE A DISEASE

HIGH CONCENTRATION PROTEIN FORMULATIONS WITH REDUCED VISCOSITY

CANCER TREATMENT COMBINATIONS

PHARMACEUTICAL COMPOSITION COMPRISING TOLL-LIKE RECEPTOR AGONIST AND STIMULATOR OF INTERFERON GENES AGONIST AND USE THEREOF

VACCINE AND METHODS FOR PREVENTING FILARIASIS AND DIROFILARIASIS

Dosing regimens and related compositions and methods

INTRAVENOUS ADMINISTRATION OF ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES

Hydrophilic antibody-drug conjugates

USE OF CLOSTRIDIUM GHONII SPORE COMBINED WITH PEMBROLIZUMAB

TREATMENT OF DISEASES OF ENDOTHELIAL DYSFUNCTION AND INFLAMMATION

METHOD FOR TREATING LIVER CIRRHOSIS BY USING COMPOSITION COMPRISING MESENCHYMAL STEM CELL, EXTRACELLULAR VESICLE PRODUCED BY MESENCHYMAL STEM CELL, AND GROWTH FACTOR

Methods for Treatment of Alport Syndrome

THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING BILIARY TRACT CANCER USING DEVIMISTAT

METHODS OF TREATING CANCER

COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MUSCLE CONDITIONS

Amorphous solid dispersions

TREATMENT OF MENTAL DISORDERS

TREATMENT OF MENTAL DISORDERS

Infusion dosage form of norepinephrine

HIGH CONCENTRATION PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST FOR OPHTHALMIC DELIVERY

COMBINATION THERAPY OF ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES AND 4-1BB (CD137) AGONISTS

ANTI-GALECTIN-9 ANTIBODIES AND THERAPEUTIC USES THEREOF

ENZYME INHIBITORS AND VIRAL INFECTION THERAPY

PROSTACYCLIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF

RADIOPHARMACEUTICAL AND METHODS

3E8.scFv.Cys-IR800 Conjugate Targeting TAG-72 in an Orthotopic colorectal cancer model

ADENO-ASSOCIATED VIRUS CAPSIDS AND ENGINEERED LIGAND-GATED ION CHANNELS FOR TREATING FOCAL EPILEPSY AND NEUROPATHIC PAIN

Compositions comprising polysaccharide-protein conjugates and methods of use thereof

Methods of Treating a Spastic Disorder in a Subject Having Underlying Condition(s)

COMPOSITIONS AND METHODS OF USE OF INTERLEUKIN-10 IN COMBINATION WITH IMMUNE CHECK-POINT PATHWAY INHIBITORS

DPEP-1 Binding Compositions and Methods of Use

DOSING REGIMENS FOR TREATMENT OF FUNGAL INFECTIONS

Composition and manufacturing processes of a toxicity free botanical drug for relief from breathing difficulties

ENGINEERED CELLS FUNCTIONALIZED WITH IMMUNE CHECKPOINT MOLECULES AND USES THEREOF

METHODS AND RELATED COMPOSITIONS FOR REDUCTION OF FAT AND SKIN TIGHTENING

Nanoparticles Containing a Taxane and their Use

Stable pharmaceutical compositions of succinylcholine chloride

VETERINARY USE AND DELIVERY OF AMMONIA OXIDIZING MICROORGANISMS

OPTIMIZED HOST/VECTOR SYSTEM FOR PRODUCING PROTECTIVE MONO- AND MULTIVALENT SUBUNIT VACCINES ON THE BASIS OF THE YEAST KLUYVEROMYCES LACTIS

POLYNUCLEOTIDE AGENTS TARGETING PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) AND METHODS OF USE THEREOF

COUPLING ENDONUCLEASES WITH END-PROCESSING ENZYMES DRIVES HIGH EFFICIENCY GENE DISRUPTION

TREATMENT OF MOST BOTHERSOME SYMPTOM (MBS) ASSOCIATED WITH MIGRAINE USING ANTI-CGRP ANTIBODIES

ULTRA-LONG ACTING INSULIN-FC FUSION PROTEINS AND METHODS OF USE

MOLECULAR SUPERSTRUCTURE AND METHODS OF USE THEREOF

Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof

SODIUM THIOSULFATE-CONTAINING PHARMACEUTICAL COMPOSITIONS

COMPOSITIONS COMPRISING MOLECULES FOR CYSTIC FIBROSIS TREATMENT

NOVEL LIPID FORMULATIONS FOR DELIVERY OF THERAPEUTIC AGENTS

Methods of Treating an Optic Disease in a Subject

GENE THERAPY OF HEMOPHILIA B USING VIRAL VECTORS ENCODING RECOMBINANT FIX VARIANTS WITH INCREASED EXPRESSION

Methods Comprising Continuous Administration of a GLP-1 Receptor Agonist and Co-administration of a Drug

Oncolytic virus improved in safety and anticancer effect

SENECA VALLEY VIRUS COMBINATION THERAPY TO TREAT A CANCER REFRACTORY TO A CHECKPOINT INHIBITOR

COMPOSITION FOR REGENERATION OF INTERVERTEBRAL DISC

IMMUNOTHERAPY FOR CANCER

SUBCUTANEOUSLY ADMINISTERED TREATMENTS FOR ADVANCED PARKINSON'S DISEASE

Methods of treating cancer with an mTOR inhibitor

DOSING REGIMEN FOR INJECTABLE CETIRIZINE

Materials and Methods for Treating Viral and Other Medical Conditions

THERAPEUTIC FORMULATIONS AND USES THEREOF

PHARMACEUTICAL DOSAGE FORM

LONG-ACTING INJECTABLE FORMULATIONS OF KETAMINE PAMOATE SALTS

ANTI-TUMOR AGENT

TREATMENT AGENT

CAS-READY MOUSE EMBRYONIC STEM CELLS AND MICE AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING DISEASE ASSOCIATED WITH DUX4 OVEREXPRESSION

Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses

Bispecific antigen-binding molecules and methods of use

ANTIBODY FUSION PROTEIN AND RELATED COMPOSITIONS FOR TARGETING CANCER

SARS-COV-2 ANTIBODIES FOR TREATMENT AND PREVENTION OF COVID-19

TOPICAL PHARMACEUTICAL COMPOSITIONS AND METHODS

MEDICAL GRADE NANOFIBRILLAR CELLULOSE HYDROGEL, A METHOD FOR TREATING A SUBJECT IN NEED OF TREATMENT OF BODY WITH IMPLANTABLE MATERIAL AND A METHOD FOR MANUFACTURING THE MEDICAL GRADE NANOFIBRILLAR CELLULOSE HYDROGEL

Compositions and methods for treatment of homocystinuria

DUAL-ADMINISTRATION METHODS FOR TREATING RESPIRATORY DISTRESS

GHRH or analogues thereof for use in treatment of hepatic disease

COMPOSITIONS COMPRISING AN RNA POLYMERASE INHIBITOR AND CYCLODEXTRIN FOR TREATING VIRAL INFECTIONS

METHODS OF TREATING ACUTE MYELOID LEUKEMIA AND MANAGING CYTOPENIA

PHARMACEUTICAL COMPOSITIONS COMPRISING PICROSIDE

ADMINISTRATION OF TESTOSTERONE COMPOSITIONS

EPINEPHRINE FORMULATIONS

EPHEDRINE LIQUID FORMULATIONS

COMPOSITION AND METHOD FOR INHIBITING ANGIOTENSINOGEN (AGT) PROTEIN EXPRESSION

CONJUGATED OLIGONUCLEOTIDES

METHODS OF TREATING AN EYE DISORDER

Compositions and methods for the treatment of carboxyhemoglobinemia

T-cell modulatory multimeric polypeptides and methods of use thereof

Nucleic acids encoding peptides that block binding of a2d-1 to glutamate receptors for treating diseases and disorders

LIQUID FORMULATION OF PROTEIN AND METHODS OF PREPARING THE SAME

METHODS FOR PREVENTING OR TREATING ALLERGY BY ADMINISTERING AN IL-4R ANTAGONIST

COMPOSITIONS AND METHODS FOR TREATING SPINAL CORD INJURIES

FORMULATIONS OF PHOSPHORAMIDATE DERIVATIVES OF NUCLEOSIDE DRUGS

FULVESTRANT FORMULATIONS

METHODS OF TREATING CANCER WITH AN MTOR INHIBITOR

PROCASPASE COMBINATION THERAPY FOR GLIOBLASTOMA

METHODS OF TREATING HEMATOLOGICAL MALIGNANCY USING NANOPARTICLE MTOR INHIBITOR COMBINATION THERAPY

SOLUBLE EPOXIDE HYDROLASE AS A TARGET FOR OCULAR DISEASES

MACROPHAGES/MICROGLIA IN NEURO-INFLAMMATION ASSOCIATED WITH NEURODEGENERATIVE DISEASES

Halogenated xanthene composition and method for treating hematologic cancers

PHARMACEUTICAL COMPOSITION

Treatment Method and Product for Uterine Fibroids using Purified Collagenase

INTRANASAL PHARMACEUTICAL DOSAGE FORMS COMPRISING NALOXONE

Octreotide Depot Formulation with Constantly High Exposure Levels

Models of tauopathy

ACUTE TREATMENT AND RAPID TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES

HIGH DOSE TREATMENTS FOR ALZHEIMER'S DISEASE

T-cell modulatory multimeric polypeptides and methods of use thereof

System and Method for Delivery of Gas to a Tissue

Coronavirus vaccine

VACCINE COMPOSITIONS

SEMAGLUTIDE FOR USE IN MEDICINE

EXTENDED RELEASE OF NEUREGULIN FOR IMPROVED CARDIAC FUNCTION

Daptomycin formulations

TREATING OPTIC NEURITIS WITH INDUCED PLURIPOTENT STEM CELL-DERIVED OLIGODENDROCYTE PRECURSOR CELLS

Methods of use for CAR T cells

COMPOSITIONS AND METHODS FOR TREATING TRANSTHYRETIN (TTR) MEDIATED AMYLOIDOSIS

Stable pharmaceutical compositions of bendamustine

FORMULATIONS OF BENDAMUSTINE

METHODS TO REDUCE HEMORRHAGE AND MORTALITY ON THE BATTLEFIELD AND APPLICATIONS FOR TRAUMA PATIENTS

METHODS AND RELATED COMPOSITIONS FOR THE TREATMENT OF CANCER

CALCIUM HYDROXYAPATITE PARTICLES AND USE THEREOF

Chimeric small molecules for the recruitment of antibodies to cancer cells

Compositions and methods for treatment of chronic lung diseases

TREATMENT OF HEADACHE USING ANTI-CGRP ANTIBODIES

Targeted Radiotherapy Chelates for In Situ Immune Modulated Cancer Vaccination

MATERIALS AND METHODS FOR TREATMENT OF PAIN RELATED DISORDERS

ADENO-ASSOCIATED VIRUS VARIANT CAPSIDS WITH IMPROVED RETINAL TRANSDUCTION AND USES THEREOF

Lyophilized powder configured for reconstitution as a liquid pharmaceutical formulation with reduced viscosity and method of preparing thereof

COMPOSITIONS COMPRISING AN ANTI-LAG-3 ANTIBODY OR AN ANTI-LAG-3 ANTIBODY AND AN ANTI-PD-1 OR ANTI-PD-L1 ANTIBODY

WIDE-SPECTRUM ANTIBACTERIAL PHARMACEUTICAL FORMULATIONS COMPRISING LYSOZYME AND METHODS OF USING THE SAME

BDNF OTIC FORMULATIONS AND USE THEREOF

METHOD FOR TREATING PAIN USING VANADIUM COMPOUNDS

Materials and Methods Relating to Stabilised Polymeric Silicate Compositions

USE OF DERIVATIVES CONTAINING C-O-P BONDS IN PATIENTS WITH KIDNEY FAILURE

LIQUID POLYMER DELIVERY SYSTEM FOR EXTENDED ADMINISTRATION OF DRUGS

Methods and compositions for treatment of epileptic disorders

Nitroxyl donors with improved therapeutic index

INJECTABLE METHODS TO TREAT DEFICIENCIES IN GLUTATHIONE METABOLISM AND HOMOCYSTINURIA

NANOPARTICLE COMPRISING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT

Inhibition of pulmonary fibrosis with nutlin-3A and peptides

Fluorescent proanthocyanidins

CROMOLYN DERIVATIVES AND RELATED METHODS OF IMAGING AND TREATMENT

USE OF PSILOCYBIN IN CANCER TREATMENT

COMPOSITIONS COMPRISING WATER THAT EXHIBITS INCREASED CELL PERMEABILITY AND METHODS OF USE THEREOF

METHODS OF TREATING MELANOCORTIN-4 RECEPTOR PATHWAY-ASSOCIATED DISORDERS

METHODS OF TREATING JOINT DISEASE, DISORDERS, AND CONDITIONS WITH TISSUE INHIBITORS OF MATRIX METALLOPROTEINASE

DETERMINISTIC MECHANOPORATION FOR CELL ENGINEERING

METHODS OF ADMINISTERING CHIMERIC ANTIGEN RECEPTOR IMMUNOTHERAPY

Methods of Treatment

CRAC CHANNEL INHIBITOR COMPOSITIONS

Pharmaceutical Compositions Comprising Sorbitan Esters

METHODS AND MATERIALS FOR TREATING BONE LOSS

Epinephrine formulations

STABLE PARENTERAL FORMULATIONS OF DULOXETINE

SLURRY AND SOLUTION COMPOSITIONS

FORMULATIONS OF ANTIBODY

FORMULATIONS OF ANTI-LAG3 ANTIBODIES AND CO-FORMULATIONS OF ANTI-LAG3 ANTIBODIES AND ANTI-PD-1 ANTIBODIES

ANTI-LAG-3 ANTIBODIES AND COMPOSITIONS

PRECISION MEDICINE FOR CHOLESTEROL TREATMENT

SAP AND PEPTIDOMIMETIC COMPOSITIONS FOR REDUCING SYMPTOMS OF INFLAMMATION

Treprostinil prodrugs

Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy

CD200 INHIBITORS AND METHODS OF USE THEREOF

Liquid neurotoxin formulation stabilized with tryptophan or tyrosine

CELL GEL PREPARATION FOR REDUCING SHEAR DAMAGE ON CELLS AND METHOD FOR REDUCING SHEAR DAMAGE ON CELLS

COMBINATION OF DEOXYRIBONUCLEASE ENZYME AND CELL THERAPIES FOR TREATMENT OF CANCER

Method for Inhibiting Reperfusion Injury

Compositions And Methods For Inducing Apopotosis In Anaerobic Cells And Related Clinical Methods For Treating Cancer And Pathogenic Infections

TRIMEPRAZINE DERIVATIVES AND COMPOSITIONS COMPRISING THE SAME FOR TREATING A NEUROPSYCHIATRIC DISORDER

PAZOPANIB PHARMACEUTICAL COMPOSITION, INJECTION AND PREPARATION METHOD AND USE THEREOF

ANETHOLE TRITHIONE ADMINISTRATION REGIMEN FOR THE PREVENTION OR TREATMENT OF ISCHEMIA-REPERFUSION INJURIES

METHODS OF TREATING LEPTOMENINGEAL METASTASIS

Dosing Regimens for Treatment of Proliferative Disorders

VILAZODONE PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF

DE NOVO BINDING DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATMENT OF THYROID EYE DISEASE

Polypeptides and medical uses thereof

[177LU] LUTETIUM-PSMA I&T COMPOSITION, KIT, METHOD OF MAKING, AND METHOD OF USING THEREOF

EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY

Preparation method and application of novel injection abiraterone derivative

FORMULATIONS OF CABAZITAXEL

ANHYDROUS SODIUM THIOSULFATE AND FORMULATIONS THEREOF

Buffered Formulations Of Exendin (9-39)

Compositions and methods for treatment of neurological disorders

METHODS FOR PRODUCING STABLE THERAPEUTIC FORMULATIONS IN APROTIC POLAR SOLVENTS

METHOD FOR PREPARING GYNOSTEMMA PENTAPHYLLUM LEAF EXTRACT AND GYNOSTEMMA PENTAPHYLLUM LEAF EXTRACT PREPARED THEREBY

Oligosaccharide compound for inhibiting intrinsic coagulation factor X-enzyme complex, and preparation method therefor and uses thereof

ANGIOTENSINOGEN-MODULATING COMPOSITIONS AND METHODS OF USE THEREOF

NEUROSTEROIDS AND ENANTIOMERS THEREOF FOR THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE CONDITIONS

Therapeutically active compounds and their methods of use

METHOD OF TREATING SCLC AND MANAGING NEUTROPENIA

METHOD OF TREATING SCLC AND MANAGING HEPATOTOXICITY

STABLE LURBINECTEDIN COMPOSITION

METHODS FOR TREATING SOFT TISSUE SARCOMA

Rifabutin treatment methods, uses, and compositions

BETA-ALETHINE, IMMUNE MODULATORS, AND USES THEREOF

PHOTOSENSITIZER MOLECULE AND USE THEREOF IN INCREASING TUMOR RETENTION TIME AND ENHANCING TREATMENT OF LARGE-VOLUME TUMORS

APPARATUS AND METHOD FOR PROTECTING NEURONS AND REDUCING INFLAMMATION AND SCARRING

SYSTEMS AND METHODS FOR NUCLEIC ACID EXPRESSION IN VIVO

ONCOLYTIC VACCINIA VIRUSES AND RECOMBINANT VIRUSES AND METHODS OF USE THEREOF

SELF-ASSEMBLED NANOPARTICLE AND USE THEREOF FOR ANTI- ANGIOGENESIS

THERAPEUTIC AGENT FOR NERVE DISORDERS

USE OF PPAR-DELTA INHIBITOR IN COMBINATION WITH IMMUNOTHERAPEUTIC DRUG FOR PREPARING ANTI-TUMOR DRUG

USE OF COMPOSITION IN TREATMENT OF CEREBRAL STROKE

Immunoregulatory microparticles for modulating inflammatory arthritides

CYSTEINE COMPOSITION AND INJECTION

INJECTABLE FORMULATION WITH ENHANCED STABILITY CONTAINING DEXIBUPROFEN AND ARGININ AND THEIR MEDICINE VESSEL FOR INJECTION

METHODS AND COMPOSITIONS FOR NUCLEIC ACID AND PROTEIN PAYLOAD DELIVERY

GATA3 INHIBITORS FOR THE TREATMENT OF TYPE-2 DIABETES AND INSULIN RESISTANCE AND PROMOTION OF SUBCUTANEOUS FAT DEPOSITION

PH20 polypeptide variants, formulations and uses thereof

PH20 polypeptide variants with a modification at position 309 of the PH20 polypeptide and a method of making thereof

Automated production of viral vectors

COMPOSITIONS AND METHODS FOR TREATING RETINAL DISEASES

TREATMENT OF FLARES IN LUPUS

ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PATIENTS WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS

Needle assisted injection device having reduced trigger force

FORMULATIONS FOR SUPRACHOROIDAL ADMINISTRATION SUCH AS HIGH VISCOSITY FORMULATIONS

Synthetic platelets

Heparin-Associated Polypeptides and Uses Thereof

POLYNUCLEOTIDES ENCODING INTERLEUKIN-12 (IL12) AND USES THEREOF

SYNTHETIC ONCOLYTIC LNP-REPLICON RNA AND USES FOR CANCER IMMUNOTHERAPY

TREATMENTS OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)

Method of reconstituting liposomal annamycin

INHALATION FORMULATIONS OF 1`-CYANO SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS

CARBIDOPA AND L-DOPA PRODRUGS AND METHODS OF USE